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Objective: This work evaluated the post-compression hardness gain of Metformin tablets made from two granulates of the same formulation, but 
with different formation principles, one by the fluidized bed and the other in a V-shaped mixer.  
Methods: The base granulate for the production of the tablets was prepared using Metformin HCL as the main active ingredient. After compression, 
the prepared tablets were tested with different evaluation parameters like relative humidity, apparent and compacted density, granulometric 
dispersion, hardness, moisture content, and friability for complete characterization. 
Results: All prepared samples were within the pre-established humidity ranges (MT1 = 3.31%, MT2 = 2.72%, MT3 = 1.73%, LF1 = 3.25%, LF2 = 
2.43% and LF3 = 1.79%). The density determination showed that the granules produced in the fluidized bed are less dense than those of the V 
mixer. LF2 sample had an apparent density of 0.525 g/ml and a compacted density of 0.546 g/ml, while the MT2 sample had an apparent density of 
0.711 g/ml and a compacted density of 0.738 g/ml, corroborating the greater porosity of granules produced in a fluidized bed. It was found that 
there is a difference in the increase in hardness between the two granulation methods. The tablets manufactured from the granules elaborated in a 
V-shaped mixer showed a greater gain in comparison with those produced in the fluid bed. The MT1 sample had the highest gain percentage, 
reaching 99.47%, 48 h after compression. The MT2 sample obtained, for the same time, 76.34%, at a much slower speed than MT1. As for the other 
samples, all increased between 24 and 42%. These results are justified by the migration of agglutination liquid that occurs during the drying step. 
Conclusion: This work demonstrated that the product Metformin 500 mg tablet has increased hardness after compression, with most significance 
in the first hour after the procedure. 
Keywords: Hardness, Post-compression, Povidone, Fluidized bed, V blender 
It was possible to verify that the tablets made from the granules produced in a V-shaped mixer have a greater 
increase in hardness than those produced by the fluidized bed, in the same humidity range. 
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/) 
DOI: https://dx.doi.org/10.22159/ijpps.2021v13i3.40311. Journal homepage: https://innovareacademics.in/journals/index.php/ijpps.  
 
INTRODUCTION  
Wet granulation is widely used in the pharmaceutical industry, to 
transform powder particles into solid aggregates, giving them 
greater density, compressibility, and mechanical resistance, better 
flow properties, as well as better homogeneity of the components, 
when comparing simple mixtures of powders [1-6]. 
Among the various technologies applied for the production of granules 
by the wet method, the fluidized bed is one of the most advantageous, 
since the mixing, granulation, and drying steps can be performed in a 
single equipment, continuously [7-10]. In this procedure, the powder 
particles are suspended by a rising air stream, receiving a jet of the 
agglutinating solution. 
It is well known in the practice of industrial routine a granulation 
technique by using V-shaped mixers, where the dry mixture is mixed 
with the 
The result of this technique is more porous 
granules since their densification occurs only by the action of capillary 
forces of the agglutinating solution liquid [11]. 
agglutinating
As the name implies, V-shaped mixers were originally designed to be 
used as mixers for solids and powders through convective 
movements of the material, producing a gentle and fluid mixture, 
moving equal portions of particles by gravitational force. The use of 
this equipment as granulators is still small compared to other 
granulation methods commonly used by the pharmaceutical 
industry [13]. This reflects a scarcity of research articles on the use 
of this equipment as granulators, which justifies our interest in 
studying this inexpensive method of obtaining granules within the 
manufacture [14]. 
 solution and later drying in circulating air 
drying ovens. This is a much less costly technique than granulation 
and drying in a fluidized bed, leading to the formation of denser 
granules, since, besides the action of the capillary forces of the 
binder solution, the diffusion principle on which the equipment's 
operation is based, helps in the approximation of solid particles, 
resulting in greater density [12]. 
During the follow-up of tablet compression processes within the 
manufacture, it was observed that some formulations that use 
granulation by the V mixer present the phenomenon of post-
compression hardness gain. This phenomenon has already been 
observed by some authors, who relate this post-compression 
hardness gain to granules obtained by the wet method with the 
moisture of the granulate after drying [15]. Besides that, another 
interfering factor would be the water balance of the tablet with the 
environment, since losing moisture to the environment would cause 
an increase in hardness over time [16]. In addition to the granule 
formation process, it is also known that the moisture in the granules 
must be in an ideal working range in order to obtain adequate 
compaction properties [17, 18]. This is one of the major factors that 
interfere with the compression response parameters, such as 
hardness and friability. 
The tests of mechanical resistance of hardness and friability are 
official within the legal context of the Brazilian Pharmacopeia, being 
these parameters for evaluation of the integral quality of the tablets. 
The hardness test determines the tablet's resistance to crushing or 
rupture under radial pressure. The hardness of a tablet is 
proportional to the compressive strength and inversely proportional 
to its porosity. The friability, on the other hand, allows determining 
the resistance of the tablets to abrasion when subjected to the action 
of specific equipment [19]. 
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The formulation used in this work was Metformin 500 mg, which 
uses Polyvinylpyrrolidone (PVP) as a binder. This polymer is very 
soluble and can make weak bonds and hydrogen bridges with 
several substances that have hydrogen acceptor groups [20]. Also, 
because of its solubility, povidone may undergo migration along 
with the solvent during drying, which may be intergranular or 
intragranular migration [21]. 
Intergranular migration usually occurs in static bed drying, in which 
the solute passes from granule to granule until it reaches the top of the 
bed. Thus, part of the granules would have the binder on its surface 
and part would not. In compression, these granules with different 
amounts of binder on the surface, resulting in different interactions 
(binder-drug, drug-drug, drug-excipient), and from a binder-drug 
bond, solid bridges will be formed. This results in an increase in 
hardness even after the compression force has been applied [22]. 
Intragranular migration, in turn, occurs in fluidized bed drying 
processes, where the granule formation takes place more 
individually. Here, the migration of the solute results in a granule 
with the binder on the surface, making it more rigid and resistant to 
deformation, resulting in little or no variation in hardness [21]. 
Therefore, this paper aims to evaluate the influence of the 
granulation process, comparing fluidized bed and V-shaped mixer, 
and the influence of the moisture of the granulate itself in the 
increase of post-compression hardness in Metformin 500 mg tablets. 
MATERIALS AND METHODS  
Granules production–formulation 
The internal formulation phase comprises the active ingredient, 
Metformin Hydrochloride (Alcon Biosciences), cornstarch (Ingredion 
Brasil), colloidal silicon dioxide (Cabot GmbH), and povidone-PVP K30 
(BASF SE). Purified water was used as a solvent in the granulation. In the 
external phase, magnesium stearate (Peter Greven Asia Sdn Bhd) and 
sodium starch glycolate (Itacel Farmoquimica Ltda) were used. As it is a 
formulation used by a commercial company, quantities cannot be 
reported in this work to respect confidentiality contracts. 
Fluidized bed granulation 
The production of the granules was carried out in a Comasa fluidized 
bed (SK developer) in sufficient quantity for the production of 1.5 kg 
of granules, which followed the steps of sieving, in 1.0 mm sieve, dry 
mixture followed by granulation and drying. In all stages, an average 
flow rate was used, with a high application rate in the granulation 
stage. The inlet temperature used for mixing and granulation was 40 
˚C and for drying it was 50 ˚C. 
a) LF1: 2.9–3.3% b) LF2: 2.2–2.6% c) LF3 1.5–1.8% 
The granulate was divided into 3 parts, 
forming the samples LF1, LF2, and LF3; each one was dried to the 
following humidity ranges:  
After reaching the humidity ranges, the granules were calibrated in a 
granulator (Comil), at 350 RPM, in a 2.0 mm sieve, mixed manually 
with the external phase ingredients, and taken for compression. 
Granulation by V mixer 
The production of the granules in the V-mixer (Lawes) used enough 
supplies to produce 5 kg of granules, which followed the steps: 
sieving, in 1.0 mm sieve, dry mix followed by wet mix. The dry 
mixture was carried out at the speed of 8 RPM, for 5 min. The binder 
solution was divided into parts and the mixture was added 
sequentially, at 8 RPM, for 5 min. After wet mixing the granulate was 
divided into 3 equal parts, forming the samples 
a) MT1: 2.9–3.3% b) MT2: 2.2–2.6% c) MT3: 1.5–1.8% 
MT1, MT2, and MT3. 
Each part was dried in a forced-air circulation oven at a temperature 
of 50 ˚C until the following humidity ranges were reached:  
After reaching the humidity ranges, the granules were calibrated in a 
granulator (Comil), at 350 RPM, in a 2.0 mm sieve, mixed manually 
with the external phase ingredients, and taken for compression. 
Determination of the relative humidity of the granulate 
Relative humidity was determined by a halogen lamp moisture 
analyzer (Mettler-Toledo HB43-S), using 5.000 g for the analysis, at 
60 ˚C [23]. 
Apparent and compacted density test 
After calibration, approximately 10 g of the granulate was weighed 
in a 50 ml graduated cylinder and the apparent volume was 
measured. After tapping the bottom of the graduated cylinder 100 
times against a soft, solid surface, the compacted volume was also 
measured following the standards preconized by the Brazilian 
Pharmacopoeia [19]. In both cases, the weight value was divided by 
the volumes obtained to determine the apparent and compacted 
densities (g/ml). The granules of the MT2 and LF2 samples were 
used, as they have moisture in the intermediate range (2.2–2.6%), 
being evaluated with the best ones for the analysis. 
Particle size dispersion test 
The used sieves (Mesh 12, 25, 45, 60, 80, and 120), were weighed 
and stacked in a decreasing way, from the smallest to the largest 
mesh, and were coupled to the vibrating table. [24] Approximately 
100 g of sample was deposited in the system and the equipment was 
activated, at intensity 10, for 20 min. After 20 min, the sieves were 
weighed to obtain the mass retained in each sieve. For the test, the 
granules of samples MT2 and LF2 were also used, as they have 
humidity in the intermediate range, between 2.2 to 2.6%. 
Compression 
The compression was effected in a Fette 102i rotary tablet press, 
with 8 stations, using a 12 mm circular punch and a speed of 37 
RPM. The tablets should reach an average weight of 596 mg (±5%), 
with an initial hardness between 5.5 and 6.5 kp. All samples were 
stored in plastic bags and kept in an environment of controlled 
temperature and humidity at 25±5 ˚C and humidity<60%, following 
the same specifications of the production area. 
Hardness analysis 
The analyzes were performed by determining the average hardness 
of 10 tablets at 0h, 1h, 12h, 24h, and 48h after compression to assess 
the product's increased hardness profile. These analyzes were 
carried out with the tablets obtained with the granules, both from 
the fluidized bed (LF1, LF2, and LF3) and from the V mixer (MT1, 
MT2, and MT3), in all established moisture ranges, following the 
analysis standards established by the Brazilian Pharmacopoeia [19]. 
A durometer (Erweka THB 125) was used for the essays. 
Friability analysis 
Friability was measured at 0h, 1h, 12h, 24h, and 48h after 
compression. The tests were carried out with the tablets obtained 
with the granules, both from the fluidized bed (LF1, LF2, and LF3), 
and from the V mixer (MT1, MT2, and MT3), in all established 
humidity ranges, following the analysis standards established by the 
Brazilian Pharmacopoeia [19]. An Erweka TAR 120/220 
friabilometer was used and a precision scale (Mettler-Toledo AL204) 
was used for the analyzes. 
Moisture evaluation 
For this test, 10 units were macerated with the aid of mortar and 
pestle, and the humidity of the powder was determined by a halogen 
lamp moisture analyzer, using 5.000 g, at 60 ˚C, at 0 h, 1 h, 12 h, 24 h, 
and 48 h after compression, to check the relationship between the 
final humidity of the tablet and the increase in post-compression 
hardness. All humidity was determined by a halogen lamp moisture 
analyzer (Mettler-Toledo HB43-S) [23]. 
RESULTS AND DISCUSSION 
All samples (MT1, MT2, MT3, LF1, LF2 and LF3) were within the pre-
established humidity ranges, being: MT1=3.31%, MT2=2.72%, 
MT3=1.73%, LF1=3.25%, LF2=2.43% and LF3=1.79%. Thus, after 
reaching the determined humidity, the granules were calibrated in a 
2.0 mm sieve and the external phase was added. Then, the 
granulometric distribution analysis was performed, and the result is 
shown in fig. 1. 
The granulometric profiles of both granules are similar, with a slight 
difference in the 25 mesh sieve, in which the granules produced in V 
mixer obtained a higher percentage of retention in comparison with 
the granules produced in the fluidized bed. Besides, the collecting 
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pan, which keeps fine particles with a diameter of less than 120 
mesh, showed a higher percentage of retention in the fluidized bed 
granules. Such results indicate that the fluidized bed produces finer 
granules than the V mixer. The density determination showed that 
the granules produced in the fluidized bed are less dense than those 
of the V mixer, since the LF2 sample had an apparent density of 
0.525 g/ml and compacted density of 0.546 g/ml, while the MT2 
sample had an apparent density of 0.711 g/ml and compacted 
density of 0.738 g/ml. As already mentioned, this result 
corroborates the greater porosity of the granules produced in the 
fluidized bed. 
After the compression step, all the resulting tablets had an average 
weight between 594.14 mg and 616.00 mg, being within the pre-
established range of 596.00±5%. Also, all tests had an initial 
hardness between 5.5 and 6.5 kp. The hardness gain tests revealed 
that all tests obtained the highest percentage of gain in the first hour 
after compression, as shown in table 1. 
 
Fig. 1: Comparison between the granulometric profiles of the granules produced by V-shaped mixer and Fluidized bed. Maximum SD V-
shaped mixer (±1.40, n=3); Fluidized bed (±1.51, n=3) 
 
 
Table 1: Comparative data between hardnesses at time 0 h, 1 h, 12 h, 24 h, and 48 h. Comparison of hardness gain percentage in 
comparison with 0 h time 
Sample Hardness 
0 h 1 h 12 h 24 h 48 h 
kp kp % kp % kp % kp % 
MT 1 5.70±0.36 10.12±1.03 77.54 10.10±0.97 77.19 10.27±0.69 80.18 11.37±0.89 99.47 
MT 2 6.55±0.25 9.13±0.67 39.39 9.79±0.23 49.01 10.07±1.12 53.34 11.55±1.23 76.34 
MT 3 6.04±0.46 7.90±0.45 30.79 8.84±0.34 46.36 8.78±0.23 45.36 8.35±0,48 38.25 
LF 1 5.73±0.23 7.34±0.14 28.10 8.15±0.61 42.26 8.52±0.74 48.69 8.15±0.58 42.23 
LF 2 6.29±0.34 8.22±0.87 30.68 8.07±0.89 28.30 8.47±0.99 34.66 8.87±0,23 41.02 
LF 3 6.55±0.20 7.62±0.23 16.34 8.82±0.91 34.66 8.47±0.56 29.31 8.16±0.40 24.58 
Number of experiments; n=10, results are expressed as mean±SD 
 
The MT1 sample had the highest gain percentage, reaching 99.47%, 
48 h after compression. The MT2 sample got, after 48 h, 76.34%, at a 
much slower speed than MT1, which obtained this value in the first 
hour of analysis. As for the other samples, all increased between 24 
and 42%. These results are justified by the migration of 
agglutination liquid that occurs during drying. As previously 
mentioned, the samples produced in V mixer and dried in the oven 
generate granules with unequal amounts of agglutination that, first, 
promote the formation of the tablet by agglutination-drug bonds. 
From this approximation of the granules, solid bridges are formed, 
giving more rigidity and resistance to the pill. Meanwhile, samples 
from the fluidized bed generate granules that have a large amount of 
agglutinating-agglutinating bonds, with little space for forming solid 
bridges. The MT3 sample, despite being produced in the same 
condition as MT1 and MT2, did not have a similar gain percentage as 
the other two because they have very low humidity, which gives 
more stiffness to the granules. For the same reason, LF3 also got a 
lower increase when compared to LF1 and LF2, as can be seen in fig. 
2. Analyzes performed after 48 h did not obtain significant results of 
increased hardness, therefore, they were disregarded in this work. 
 
 
Fig. 2: Comparison of post-compression hardness increase of granules obtained by V-shaped mixer (A) and fluidized bed (B). Maximum 
SD (A) V-shaped mixer (±0.78, n=10); (B) Fluidized bed (±0.67, n=10) 
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In fig. 3 we can see that in the same humidity ranges, the granules 
produced in a V mixer have a more evident hardness increase than 




Fig. 3: Comparison of the post-compression hardness increase between V-shaped mixer and fluidized bed with the same humidity range. 
Maximum SD V-shaped mixer (±0.78, n=10); Fluidized bed (±0.67, n=10) 
 
In the friability assessments, as seen in table 2, we found that MT1 
has the lowest friability among all samples, both initially and 
throughout the analysis times. The MT3 and LF3 samples, which had 
granular moisture in the lower range, between 1.5 to 1.8%, obtained 
the highest friability values, being even outside the specification of 
the Brazilian Pharmacopeia [19], which defines that the values 
should not be greater than 1.5%. In the analyzes, these samples 
presented tablets with a high incidence of chipped edges, in addition 
to units with capping and broken tablets. The cause of these events 
is related to the mass moisture itself since a very low humidity tends 
to form porous and friable tablets, with low mechanical resistance 
[25, 26]. 
 
Table 2: Comparative data between friability at time 0h, 1 h, 12 h, 24 h, and 48 h 
Sample Friability (%) 
0 h 1 h 12 h 24 h 48 h 
MT 1 0.338±0.076 0.216±0.055 0.369±0.044 0.299±0.012 0.132±0.060 
MT 2 0.430±0.089 0.146±0.041 0.302±0.051 0.352±0.039 0.218±0.034 
MT 3 3.736±0.239 3.376±0.359 0.825±0.038 0.805±0.067 0.534±0.065 
LF 1 0.557±0.062 0.413±0.067 0.208±0.085 0.232±0.041 0.226±0.092 
LF 2 1.155±0.588 0.979±0.107 0.667±0.088 0.701±0.048 0.542±0.085 
LF 3 6.146±0.827 1.983±0.588 0.815±0.067 1.070±0.075 0.794±0.057 
Number of experiments; n=20, results are expressed as mean±SD 
 
When comparing samples from the same humidity range, such as 
MT1 and LF1, we find that samples produced in the V-shaped mixer 
have lower friability than samples produced in the fluidized bed. 
This is due to the principle of the formation of granules. The 
granules produced in a fluidized bed rely only on the cohesive forces 
of the agglutination solution, forming less dense and consequently 
more friable granules. While the granules produced by the V mixer, 
besides the cohesion forces, have a greater approximation of the 
particles because of the diffusion promoted by the equipment, 
resulting in denser granules [27]. In the MT3 and LF3 samples, the 1 
h analyzes do not respond to this pattern, with the mixer friability 
being greater than that of the fluidized bed. However, the final 
values remained in the standard of the other tests. 
According to the moisture analysis carried out, the humidity 
variation during the 48 h verified was between 0.10 and 0.23%, for 
all samples. However, the uncertainty of the humidity balance used 
in this work is 0.20% [23]. Therefore, we verified that the granular 
humidity was not an interfering factor in the increase of post-
compression hardness. 
CONCLUSION 
This work demonstrated that the product Metformin 500 mg tablets 
have increased post-compression hardness, with greater 
significance in the first hour after the process. It was possible to 
verify that the tablets made from the granules produced in a V-
shaped mixer have a greater increase in hardness than those 
produced by the fluidized bed, in the same humidity range. This 
occurs because of the mechanisms of agglutination liquid migration 
induced by drying, which are intergranular migration and 
intragranular migration, respectively. It was also observed that in 
the lowest humidity range, between 1.5 to 1.8%, the MT3 and LF3 
samples had similar results of hardness and friability, because in this 
humidity range the granules become rigid, suffering little 
deformation, producing porous and friable tablets. Regarding the 
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humidity of the tablets, we found that it did not change during the 
analysis time, so it did not influence the increase in hardness. 
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